Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-10-20
1989-04-18
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142302, 514300, 544101, 546123, 546156, A61K 3147, C07D40102, C07D40104
Patent
active
048228010
ABSTRACT:
Novel naphthyridine-, quinoline- and benzoxazinecarboxylic acids as antibacterial agents are described as well as methods for their manufacture, formulation, and use in treating bacterial infections including the description of certain novel intermediates used in the manufacture of the antibacterial agents.
REFERENCES:
patent: 4049811 (1977-09-01), Berger et al.
patent: 4571396 (1986-02-01), Hull et al.
patent: 4604401 (1986-08-01), Mich et al.
patent: 4665079 (1987-05-01), Culbertson et al.
patent: 4780408 (1988-10-01), Bridges et al.
Domagala John M.
Mich Thomas F.
Sanchez Joseph P.
Anderson Elizabeth M.
Raymond Richard L.
Warner-Lambert & Company
LandOfFree
4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antib does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antib, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antib will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2397137